journal article·2016-07-03Open access

Synthesis and evaluation of single-wall carbon nanotube-paclitaxel-folic acid conjugate as an anti-cancer targeting agent

Sara Tavakolifard, Esmaeil Biazar, Khalil Pourshamsian, Mohammad H. Moslemin

Abstract

Single-wall carbon nanotubes (SWCNT) represent a novel nanomaterial applied in various nanotechnology fields because of their surface chemistry properties and high drug cargo capacity. In this study, SWCNT are pre-functionalized covalently with paclitaxel (PTX) - an anticancer drug, and folic acid (FA), as a targeting agent for many tumors. The samples are investigated and evaluated by different analyses such as Fourier transform infrared (FT-IR) spectroscopy, scanning electron microscopy (SEM), thermal gravimetric analysis (TGA), absorption spectroscopic measurements (UV-Visible), elemental analysis, and cell analyses with cancer cell line cultures. The results show good conjugation of the targeting molecule and the anticancer drug on the surface of the carbon nanotubes (CNT). This work demonstrates that the SWCNT-PTX-FA system is a potentially useful system for the targeted delivery of anticancer drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Carbon Nanotubes in Composites · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Science and Research Branch, Islamic Azad University, Yazd, Iran

Department of Biomaterials Engineering, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran

Department of Chemistry, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran

References (34)

Show source-provided references
1. 10.1039/b201013p10.1039/b201013p ↗
2. 10.1002/adma.20040134010.1002/adma.200401340 ↗
3. 10.1021/nn800551s10.1021/nn800551s ↗
4. 10.1039/b410943k10.1039/b410943k ↗
5. 10.1039/b507451g10.1039/b507451g ↗
6. 10.1021/ja010172b10.1021/ja010172b ↗
7. 10.1126/science.282.5386.9510.1126/science.282.5386.95 ↗
8. 10.1021/ja046631110.1021/ja0466311 ↗
9. 10.1038/nbt87510.1038/nbt875 ↗
10. 10.1016/S0039-6028(01)01558-810.1016/S0039-6028(01)01558-8 ↗
11. 10.1016/j.nano.2009.07.00310.1016/j.nano.2009.07.003 ↗
12. 10.1016/j.actbio.2008.05.01810.1016/j.actbio.2008.05.018 ↗
13. Grecory RE · Clin Pharm · 1993 · 12 · 401
14. 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N ↗
15. 10.1073/pnas.050268010210.1073/pnas.0502680102 ↗
16. 10.1021/ja053962k10.1021/ja053962k ↗
17. 10.1126/science.227.4689.84910.1126/science.227.4689.849 ↗
18. 10.1038/nnano.2006.17010.1038/nnano.2006.170 ↗
19. 10.1002/anie.20060429510.1002/anie.200604295 ↗
20. 10.1021/nn700040t10.1021/nn700040t ↗
21. 10.1007/s12274-009-9009-810.1007/s12274-009-9009-8 ↗
22. 10.1021/nn901122510.1021/nn9011225 ↗
23. 10.3844/ajnsp.2011.106.11110.3844/ajnsp.2011.106.111 ↗
24. 10.1038/364464a010.1038/364464a0 ↗
25. 10.1126/science.107263110.1126/science.1072631 ↗
26. 10.1038/nnano.2008.11110.1038/nnano.2008.111 ↗
27. 10.1021/ar700089b10.1021/ar700089b ↗
28. 10.1080/71385395610.1080/713853956 ↗
29. 10.1016/j.carbon.2005.10.01110.1016/j.carbon.2005.10.011 ↗
30. 10.1021/ar010160v10.1021/ar010160v ↗
31. 10.1021/ja045077s10.1021/ja045077s ↗
32. 10.5101/nbe.v3i3.p157-16210.5101/nbe.v3i3.p157-162 ↗
33. 10.1088/0957-4484/19/04/04510210.1088/0957-4484/19/04/045102 ↗
34. 10.1093/toxsci/kfg22810.1093/toxsci/kfg228 ↗